Disclaimers

Disclaimer for news and press releases

The information contained in these releases was current on the date the releases were issued and will become outdated over time. While this information was believed to be accurate as of the date prepared, CombinatoRx, Incorporated disclaims any duty or obligation to update such information.

General disclaimer

CombinatoRx will use reasonable efforts to provide accurate and up-to-date information on its website, www.combinatoRx.com, but CombinatoRx will assume no responsibility for the accuracy of such information. The information available on www.combinatoRx.com is subject to change at any time without notice. CombinatoRx makes no warranties or representations of any kind, express or implied, with respect to the information and content on this website including, but not limited to, warranties of merchantability or fitness for a particular purpose. All users agree that all access to and use of www.combinatoRx.com, as well as any content provided or available thereon, is entirely at their own risk. Neither CombinatoRx nor any party involved in creating, producing or delivering this website shall be liable to any person for any direct, incidental, special, consequential, indirect or punitive damages arising out of access to, use of, reliance on, or inability to use www.combinatoRx.com nor for any errors, inaccuracies or omissions that may be present in any of the content contained on or otherwise available through this website.

Information for investors

We have filed a registration statement, which includes a prospectus, on Form S-1 with the Securities and Exchange Commission regarding a proposed offering of our stock. The information contained in, or that can be accessed through, this website is not incorporated by reference into our prospectus and is not part of our prospectus. Potential investors should rely only on the information contained in the prospectus. We have not authorized anyone to provide you with information that is different.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this website regarding CombinatoRx, Incorporated's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Forward-looking statements can be identified by, among other things, the use of forward looking language, such as "anticipate," "believe," "could," "estimate," "expect," "future," "intends," "may," "plans," "should," "seeks," "potential," "will," or the negative of those terms, or other variations of those terms of comparable language, or by discussions of strategy or intentions. A number of important factors could cause actual results to differ materially from those projected or suggested in the forward looking statements including, but not limited to, the ability of CombinatoRx to: (i) successfully consummate the initial public offering, (ii) discover product candidates, (iii) successfully conduct preclinical and clinical trials of product candidates, (iv) obtain regulatory approval of any product candidates, (v) obtain and enforce intellectual property rights and (vi) the effect of capital market conditions and additional financing requirements. The Company assumes no obligation or responsibility to update or revise this website. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in our registration statement filed with the Securities and Exchange Commission.